GM2 ganglioside

Europe PMC · fetched just now · sorted by publication date

1. 1
   Inborn Errors of Metabolism: Pathophysiological Insights, Diagnostic Advances, and Evolving Treatment Paradigms.

   Sadaria R. · 2026-06-19

   open access unreviewed
2. 2
   Miglustat in Neuronopathic Lysosomal Storage Disorders: Biological Rationale, Clinical Evidence, and Limits of Repurposing.

   Lipiński P, Węgrzyn G. · 2026-09-19

   open access unreviewed
3. 3
   Unlocking the Potency of Keyhole Limpet Hemocyanin: Structural Insights, Immunological Mechanisms, and Therapeutic Frontiers.

   Cermakova P, Cehlar O, Piestansky J. · 2026-09-05

   open access unreviewed
4. 4
   <i>APOE</i> Genotypes Modulate the Relationship of Hypertension With Alzheimer's Disease: Associations and Clues of Peripheral Mechanisms.

   Wu HY, Hou JH, Huang LY, Tan L, Xu W. · 2026-06-22

   open access unreviewed
5. 5
   Application of Mesenchymal Stromal Cells and Their Exosomes in Neurodegenerative Diseases and Lysosomal Storage Diseases.

   Ayupova AI, Sidorova AS, Luzina EA, Sufianov AA, Sufianova GZ, Zaynutdinov AM, Rizvanov AA, Solovyeva VV. · 2026-08-26

   open access unreviewed
6. 6
   Advances in Therapeutic Melanoma Vaccines (2010-2025).

   Bian MY, Stevens R, Mangla A, Mitra D, Zaorsky NG, Bordeaux JS, Rothermel LD. · 2026-08-07

   open access unreviewed
7. 7
   Modeling Tay-Sachs Disease in Astrocyte-like Cells Reveals Significant Changes in the Transcriptomic Profile.

   Suárez-García DA, Espejo-Mojica AJ, Alméciga-Díaz CJ. · 2026-07-22

   open access unreviewed
8. 8
   Anti-Alpha-Gal Antibodies Against Gangliosides: Preliminary Data on a New Autoimmune Target in Alzheimer's Disease Patients.

   Naso F, Gandaglia A, Sturaro G, Lepore A, Arcaro A, Gentile F, Di Costanzo A, Angiolillo A. · 2026-07-10

   open access unreviewed
9. 9
   From farm to lab: gene-edited sheep transforming bone research.

   Lunde-Young R, Huggins S, Pryor JH, Westhusin ME, Muneoka K, Murphy WJ, Suva LJ, Long CR, Gaddy D. · 2026-04-11

   open access unreviewed
10. 10
    Light-Switched Mesenchymal Stem Cells for In Situ Exosome Amplification in Craniofacial Bone Defect Reconstruction.

    Wu T, Liu Y, Wang S, Bai X, Zhang L, Liu Y, Fu Z, Shi C. · 2026-05-06

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.